Sign in to view content

Phase 1/2 Clinical Trial of Intravitreal 4D-125 AAV Gene Therapy in Patients with Advanced XLRP: Interim Safety & Preliminary Activity

Cagri G Besirli, MD, PhD, FASRS

Video
Published 2021

Related

Ixoberogene Soroparvovec (Ixo-vec) IVT Gene Therapy for Neovascular AMD: Phase 2 LUNA Study Update
Glenn C. Yiu, MD, PhD
Updates from the Field
2025
Gene Therapy in Pediatric Retina Patients at the Bascom Palmer Eye Institute: What I Have Learned
Audina M. Berrocal, MD FASRS
Annual Meeting Talks
2019
First Time Results of VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy
Omer Trivizki, MD, MBA
Updates from the Field
2025

Category: Hereditary Retinal Disease & Genetics

See more